CAMILE SHAMBLIN: Open Payments
NPI 1639760457 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,626 in 123 payments from 19 companies in 2025. Trend: 2023 $259 · 2024 $3,156 · 2025 $2,626
Food & beverage: $2,626
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 15 | $492 |
| Amgen Inc. | 29 | $483 |
| ABBVIE INC. | 20 | $333 |
| Novartis Pharmaceuticals Corporation | 16 | $309 |
| Janssen Biotech, Inc. | 8 | $169 |
| GENZYME CORPORATION | 7 | $155 |
| GlaxoSmithKline, LLC. | 2 | $145 |
| Mallinckrodt Hospital Products Inc. | 5 | $110 |
| AstraZeneca Pharmaceuticals LP | 4 | $84 |
| E.R. Squibb & Sons, L.L.C. | 4 | $81 |
Products named: Bimzelx, COSENTYX, ENBREL, RINVOQ, EVENITY, KEVZARA, SKYRIZI, BENLYSTA.
Industry payments across FL — which companies pay providers there.
